复发/转移性乳腺癌的临床试验
总计17852个结果
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Hellenic Cooperative Oncology GroupHellenic Society of Medical Oncology主动,不招人
-
Spanish Breast Cancer Research GroupBristol-Myers Squibb完全的
-
MedSIR完全的
-
SOLTI Breast Cancer Research GroupNovartis; Roche Pharma AG; Guardant Health, Inc.主动,不招人
-
Japan Breast Cancer Research GroupChugai Pharmaceutical完全的
-
University of Maryland, BaltimoreGenentech, Inc.终止
-
Abramson Cancer Center of the University of Pennsylvania终止
-
Seoul National University HospitalSeoul National University Bundang Hospital; Korean Cancer Study Group (KCSG); Eisai Korea Inc.; Ono...主动,不招人
-
Eisai Inc.Halozyme Therapeutics终止
-
Samsung Medical Center未知
-
Hoffmann-La Roche终止
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.终止
-
EpiAxis TherapeuticsThe Canberra Hospital; Southern Medical Day Care Centre; Liverpool Cancer Therapy Centre完全的
-
University of Alabama at BirminghamGenentech, Inc.完全的
-
AstraZeneca完全的
-
University of Kansas Medical Center终止
-
Milton S. Hershey Medical CenterAvon Foundation完全的
-
Samsung Medical Center未知
-
Hospital San Carlos, MadridComplexo Hospitalario Universitario de A Coruña完全的
-
ETOP IBCSG Partners FoundationBreast International Group完全的
-
Hoffmann-La Roche完全的转移性乳腺癌美国, 大韩民国, 英国, 意大利, 俄罗斯联邦, 阿根廷, 比利时, 巴西, 巴拿马, 德国, 日本, 乌克兰, 智利, 南非, 保加利亚, 罗马尼亚
-
Gary SchwartzUniversity of Colorado, Denver; North Shore University Hospital终止
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences完全的
-
Weill Medical College of Cornell UniversityBristol-Myers Squibb完全的
-
Hebei Medical University Fourth Hospital未知
-
Cancer Institute and Hospital, Chinese Academy...未知